Literature DB >> 29153191

Atresiaplasty in Congenital Aural Atresia: What the Facial Plastic Surgeon Needs to Know.

Douglas S Ruhl1, Bradley W Kesser2.   

Abstract

Patients with microtia and congenital aural atresia should have a comprehensive hearing assessment early in life. Options for hearing habilitation should be presented, and children with bilateral aural atresia should be fitted with a bone conducting hearing device to support normal speech and language development. If atresia surgery is pursued, the microtia surgeon must be aware of certain principles. This article presents recommendations on options for potentially improving hearing in children with congenital aural atresia: assessing surgical candidacy; chronology and timing of surgeries; functional importance of certain ear structures; and understanding the possible locations of an aberrant facial nerve to avoid injury in these patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atresia; Atresia surgery; Atresiaplasty; Canalplasty; Conductive hearing loss; Congenital aural atresia; Microtia; Otologist

Mesh:

Year:  2018        PMID: 29153191     DOI: 10.1016/j.fsc.2017.09.005

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN: 1064-7406            Impact factor:   1.918


  3 in total

1.  A novel auricular prosthesis which incorporates a cartilage conduction hearing aid based on 3D data processing technique: a preclinical evaluation.

Authors:  Takanori Nishiyama; Shintaro Hayashi; Naoki Oishi
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-11       Impact factor: 2.503

2.  Microtia and cholesteatoma: Implications for the reconstructive surgeon.

Authors:  R M van Hogezand; A L Smit; C C Breugem
Journal:  JPRAS Open       Date:  2021-02-09

3.  Acute Otitis Media and Facial Paralysis in an Infant with Aural Atresia: Management of a Rare Case.

Authors:  Kerem Kökoğlu; Mehmet İlhan Şahin
Journal:  J Int Adv Otol       Date:  2021-03       Impact factor: 1.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.